UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-QSB

(Mark  One)

[X]     QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE
        SECURITIES  EXCHANGE  ACT  OF  1934

        For  the  quarterly  period  ended  September  30,  2006

                                       OR

[ ]     TRANSITION  REPORT  PURUSANT  TO  SECTION  13  OR  15(d)  OF  THE
        SECURITIES  EXCHANGE  ACT  OF  1934

                        Commission file number 33-19598-D

                                    VYTA CORP
                                    ---------
        (Exact name of small business issuer as specified in its charter)

                Nevada                             84-0992908
                ------                             ----------
     (State or other jurisdiction of            (I.R.S. employer
      incorporation or organization)         identification  number)

                           370 17th Street, Suite 3640
                             Denver, Colorado 80202
                    (Address of principal executive offices)

         Issuer's telephone number, including area code:  (303) 592-1010

Check  whether  the  issuer  (1)  has  filed all reports required to be filed by
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports),  and  (2) has been subject to such filing requirements for the past 90
days.      Yes  X   No
               ---     ---

Indicate  by check mark whether the registrant is a shell company (as defined in
Rule  12b-2  of  the  Exchange  Act).     Yes       No  X
                                              ---      ---

State the number of shares outstanding of each of the issuer's classes of common
equity,  as  of  the  latest  practicable  date:

As of November 15, 2006 there were 22,643,512 shares of the registrant's sole
class of common shares outstanding.

Transitional  Small  Business  Disclosure  Format     Yes      No  X
                                                          ---     ---


<PAGE>
<TABLE>
<CAPTION>
PART I - FINANCIAL INFORMATION
<S>       <C>                                                                    <C>
Item 1. Financial Statements (Unaudited)                                       Page
                                                                               ----

        Condensed Consolidated Balance Sheet -September 30, 2006                F-1

        Condensed Consolidated Statements of Operations  -
          Three months ended September 30, 2006 and 2005                        F-2

        Condensed Consolidated Statements of Comprehensive
          Loss - Three months ended September 30, 2006 and 2005                 F-3

        Condensed Consolidated Statement of Changes in Shareholders'
          Equity -Three months ended September 30, 2006                         F-4

        Condensed Consolidated Statements of Cash Flows -
          Three months ended September 30, 2006 and 2005                        F-5

        Notes to Condensed Consolidated Financial Statements                    F-7

Item 2. Management's Discussion and Analysis                                     1

Item 3. Controls and Procedures                                                  3

PART II - OTHER INFORMATION

Item 1. Legal Proceedings -Not Applicable                                        4

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
          - Not Applicable                                                       4

Item 3. Defaults Upon Senior Securities - Not Applicable                         4

Item 4. Submission of Matters to a Vote of Security Holders - Not Applicable     4

Item 5. Other Information - Not Applicable                                       4

Item 6. Exhibits                                                                 5

SIGNATURES                                                                       6
</TABLE>


<PAGE>
<TABLE>
<CAPTION>
                          PART I - FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS


                            VYTA CORP AND SUBSIDIARIES
                       Condensed Consolidated Balance Sheet
                                September 30, 2006
                                    (Unaudited)

                                     Assets
                                     ------
<S>                                                                  <C>
Current assets:
  Cash and cash equivalents                                          $     11,845
  Prepaid expenses and other                                              321,383
                                                                     -------------
    Total current assets                                                  333,228
                                                                     -------------

Property and equipment:
  Office equipment and furniture                                           67,107
  Less accumulated depreciation                                           (57,629)
                                                                     -------------
                                                                            9,478
                                                                     -------------

Other assets:
  Deposits and other                                                       19,373
  Notes receivable, equity investee(Note 2)                             1,720,238
  Investment in equity investee (Note 3)                                  198,747
                                                                     -------------
                                                                        1,938,358
                                                                     -------------

        Total assets                                                 $  2,281,064
                                                                     =============

                      Liabilities and Shareholders' Equity
                      ------------------------------------

Current liabilities:
  Accounts payable                                                   $     90,572
  Advances payable, related party (Note 4)                                240,000
  Accrued liabilities                                                       7,063
                                                                     -------------
    Total liabilities  (all current)                                      337,635
                                                                     -------------

Commitments and contingencies (Notes 4 and 6)

Shareholders' equity:
  Preferred stock; $0.0001 par value; 5,000,000 shares authorized;
    none issued and outstanding
  Common stock; $0.0001 par value; 200,000,000 shares authorized;
    22,643,512 shares issued and outstanding                                2,264
  Additional paid-in capital                                           28,390,883
  Accumulated other comprehensive income                                  130,394
  Accumulated deficit                                                 (26,580,112)
                                                                     -------------
      Total shareholders' equity                                        1,943,429
                                                                     -------------

        Total liabilities and shareholders' equity                   $  2,281,064
                                                                     =============
</TABLE>

See notes to condensed consolidated financial statements.


                                     F-1
<PAGE>
<TABLE>
<CAPTION>
                           VYTA CORP AND SUBSIDIARIES
                 Condensed Consolidated Statements of Operations
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

                                            2006         2005
                                        ------------  -----------
<S>                                     <C>           <C>
Revenues                                $         -            -
                                        ------------  -----------

General and administrative expense         (275,414)    (224,429)
                                        ------------  -----------

Loss from operations                       (275,414)    (224,429)
                                        ------------  -----------

Other income (expense):
  Other income                                    -       28,585
  Interest income                                 -        3,931
  Equity losses of equity investees
    (Note 3)                               (267,558)    (259,908)
  Interest expense                                -     (235,109)
  Interest expense, related party                 -         (219)
                                        ------------  -----------
                                           (267,558)    (462,720)
                                        ------------  -----------

Net loss                                $  (542,972)    (687,149)
                                        ============  ===========

Net loss per share, basic and diluted
  (Note 1)                              $     (0.02)       (0.12)
                                        ============  ===========

Weighted average number of common
  shares outstanding (Note 1)            22,643,512    5,776,593
                                        ============  ===========
</TABLE>

See notes to condensed consolidated financial statements.


                                     F-2
<PAGE>
<TABLE>
<CAPTION>
                           VYTA CORP AND SUBSIDIARIES
             Condensed Consolidated Statements of Comprehensive Loss
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

                                         2006          2005
                                     ------------  ------------
<S>                                  <C>           <C>
Net loss                             $  (542,972)     (687,149)

Change in unrealized gain (loss) on
  securities                                  35           (14)
                                     ------------  ------------


Comprehensive loss                   $  (542,937)     (687,163)
                                     ============  ============
</TABLE>

See notes to condensed consolidated financial statements.


                                     F-3
<PAGE>
<TABLE>
<CAPTION>
                                          VYTA CORP AND SUBSIDIARIES
                      Condensed Consolidated Statement of Changes in Shareholders' Equity
                                     Three Months Ended September 30, 2006
                                                  (Unaudited)

                                                                    Accumulated
                                 Common stock         Additional      other                           Total
                          -------------------------    paid-in     comprehensive   Accumulated    shareholders'
                            Shares        Amount       capital        income         deficit         equity
                          -----------  ------------  ------------  -------------  --------------  -------------
<S>                       <C>          <C>           <C>           <C>            <C>             <C>
Balances, July 1, 2006     22,643,512  $      2,264  $ 28,390,883  $     130,359  $ (26,037,140)  $  2,486,366

Net loss                            -             -             -              -       (542,972)      (542,972)

Change in unrealized
  gain on securities                -             -             -             35              -             35
                          -----------  ------------  ------------  -------------  --------------  -------------
Balances,
  September 30, 2006       22,643,512         2,264    28,390,883        130,394    (26,580,112)     1,943,429
                          ===========  ============  ============  =============  ==============  =============
</TABLE>

See notes to condensed consolidated financial statements.


                                     F-4
<PAGE>
<TABLE>
<CAPTION>
                               VYTA CORP AND SUBSIDIARIES
                     Condensed Consolidated Statements of Cash Flows
                     Three Months Ended September 30, 2006 and 2005
                                       (Unaudited)

                                                                   2006           2005
                                                               -------------  ------------
<S>                                                            <C>            <C>
Cash flows from operating activities:
  Net loss                                                     $   (542,972)     (687,149)
                                                               -------------  ------------
  Adjustments to reconcile net loss to net cash used
    in operating activities:
    Amortization                                                    117,689        22,500
    Depreciation                                                      1,346         1,425
    Equity losses of equity investees                               267,558       259,908
    Amortization of discounts on notes payable                            -       213,760
    Changes in operating assets and liabilities:
      Decrease (increase) in prepaid expenses and other              15,143        (2,907)
      Increase (decrease) in accounts payable                        11,722       (39,353)
      Increase in accrued liabilities                                     -         1,034
                                                               -------------  ------------
  Total adjustments                                                 413,458       456,367
                                                               -------------  ------------

        Net cash used in operating activities                      (129,514)     (230,782)
                                                               -------------  ------------

Cash flows from investing activities:
    Increase in notes receivable, equity investee                  (191,000)            -
    Investment in joint venture                                           -      (500,000)
                                                               -------------  ------------
        Net cash used in investing activities                      (191,000)     (500,000)
                                                               -------------  ------------

Cash flows from financing activities:
    Exercise of warrants for cash                                         -     1,535,000
    Proceeds to be applied to subscribed preferred stock            140,000             -
    Payment of notes payable                                              -      (960,663)
    Proceeds from issuance of notes payable and common stock              -       150,000
                                                               -------------  ------------
        Net cash provided by financing activities                   140,000       724,337
                                                               -------------  ------------

Net decrease in cash and cash equivalents                          (180,514)       (6,445)

Cash and cash equivalents, beginning                                192,359        25,835
                                                               -------------  ------------

Cash and cash equivalents, ending                              $     11,845        19,390
                                                               =============  ============
</TABLE>

                                  (Continued)


                                     F-5
<PAGE>
<TABLE>
<CAPTION>
                           VYTA CORP AND SUBSIDIARIES
                 Condensed Consolidated Statements of Cash Flows
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)
                                   (Continued)

                                                                   2006           2005
                                                               -------------  ------------
<S>                                                            <C>            <C>
Supplemental disclosure of cash flow information:
  Cash paid for interest                                       $          -         1,069
                                                               =============  ============

Supplemental disclosure of non-cash investing and financing
  activities:
    Issuance of common stock in connection with notes payable  $          -       117,886
                                                               =============  ============
    Advances receivable applied to equity investment           $          -       405,000
                                                               =============  ============
    Equity investment acquired in exchange for note payable    $          -       595,000
                                                               =============  ============
    Forgiveness of accrued payroll owed to
      officer/shareholder                                      $          -         8,750
                                                               =============  ============
</TABLE>

See notes to condensed consolidated financial statements.


                                     F-6
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

1.   BASIS OF  PRESENTATION,  MANAGEMENT'S  PLANS  AND  SUMMARY  OF  SIGNIFICANT
     ACCOUNTING  POLICIES:

Presentation  of  Interim  Information:

The  accompanying  condensed  consolidated  financial  statements  include  the
accounts  of  Vyta  Corp,  a  Nevada corporation (the Company), its wholly-owned
subsidiaries,  NanoPierce Connection Systems, Inc., a Nevada corporation (NCOS),
and  ExypnoTech,  LLC  (ET  LLC).  All  significant  intercompany  accounts  and
transactions  have  been  eliminated  in  consolidation.  NCOS and ET LLC had no
revenues  or  operations in 2006 and 2005. The Company has two investments which
are  accounted  for  using  the equity method of accounting. These equity method
investments  consist  of  ExypnoTech, GmbH (EPT) and BioAgra, LLC (BioAgra)(Note
3).  The  Company's  equity investees, EPT and BioAgra, operate in two segments,
the  RFID  industry  and  the  animal  feed  industry,  respectively.

In  the  opinion  of  the  management of the Company, the accompanying unaudited
condensed  consolidated  financial  statements include all material adjustments,
including  all normal and recurring adjustments, considered necessary to present
fairly  the  financial  position  and  operating  results of the Company for the
periods presented. The financial statements and notes are presented as permitted
by Form 10-QSB, and do not contain certain information included in the Company's
Annual  Report  on  Form  10-KSB  for the fiscal year ended June 30, 2006. It is
management's  opinion  that  when  the  interim financial statements are read in
conjunction with the June 30, 2006 Annual Report on Form 10-KSB, the disclosures
are  adequate  to make the information presented not misleading. Interim results
are  not necessarily indicative of results for a full year or any future period.

Management's  Plans:

In the Company's Annual Report on Form 10-KSB for the fiscal year ended June 30,
2006,  the  Report of the Independent Registered Public Accounting Firm includes
an  explanatory  paragraph  that describes substantial doubt about the Company's
ability  to  continue  as  a  going  concern.  The  Company's  interim financial
statements for the three months ended September 30, 2006 have been prepared on a
going  concern  basis,  which  contemplates  the  realization  of assets and the
settlement  of liabilities and commitments in the normal course of business. The
Company reported a net loss of $542,972 for the three months ended September 30,
2006,  and  an  accumulated deficit of $26,580,112 as of September 30, 2006. The
Company  also  has  a  working  capital deficiency at September 30, 2006 and the
Company  has  not  recognized  any  revenues  from  its  business  operations.

The  Company's  ability  to  continue as a going concern may be dependent on the
success  of  management's plans discussed below. The financial statements do not
contain  any  adjustments  relating  to the recoverability and classification of
assets  or the amounts and classification of liabilities that might be necessary
should  the  Company  be  unable to continue as a going concern. During the 2007
fiscal year, the Company intends to continue its efforts to assist BioAgra (Note
3)  with the continuing development of its sales, nationally and internationally
in  other  animal  feed  markets,  such  as the equine and the swine markets. In
addition,  the  Company  has  begun  negotiations


                                     F-7
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

with  interested  parties, to license its NCOS(TM) technology.  At this time, no
terms  have  been  finalized.

The  Company  also  intends  to raise funds to support operations of the Company
during  the  2007 fiscal year through a private offering of preferred stock, the
terms  of  which  are  being  negotiated.

Currently,  the  Company  does  not  have  a  revolving  loan agreement with any
financial institution, nor can the Company provide any assurance it will be able
to  enter  into  any  such  agreement  in  the future, or be able to raise funds
through  a  further  issuance  of  debt  or  equity  in  the  Company.

Deferred Consulting Costs:

In  June  2006,  the  Company  entered  into  a twelve-month consulting services
agreement  with  two  third  parties,  in  which  the  parties agreed to provide
lobbying and public relation services.  Compensation consisted of 200,000 shares
of  the  Company's  common  stock  with a market value of approximately $182,000
(based  on a closing market price of $0.91 per share at the date the transaction
was  entered  into)  and  a  warrant to purchase 500,000 shares of the Company's
common  stock,  with an exercise price of $0.91 per share and a term of 3 years.
The warrant was valued at $283,000 using the Black-Scholes pricing model method.
The deferred cost is being amortized on a straight-line basis as earned over the
twelve-month  period  from  the  date of the agreement.  During the three months
ended  September  30,  2006,  $117,689  was  expensed.

In  June  2005,  the  Company  entered  into  a twelve-month consulting services
agreement  with  a third party, in which this party agreed to provide public and
investor  relation  services  and general business services for the twelve-month
term  of  the  agreement.  Compensation  consisted  of  1,000,000  shares of the
Company's  restricted  common stock with a market value of approximately $90,000
(based  on  the  closing  market  price  of  $0.09  per share at the date of the
transaction).  The  deferred  cost  was  amortized  on  a straight-line basis as
earned over the twelve-month period from the date of the agreement and therefore
has  been  fully-amortized.  During  the  three months ended September 30, 2005,
$22,500  was  expensed.

Loss Per Share:

Basic  Earnings  Per  Share  (EPS)  excludes dilution.  Diluted EPS reflects the
potential  dilution  that  could occur if securities or other contracts to issue
common  stock  were  exercised or converted into common stock or resulted in the
issuance  of  common stock that then shared in the earnings of the entity.  Loss
per  share  of  common stock is computed based on the weighted average number of
common shares outstanding during the period.  Stock options and warrants are not
considered  in  the  calculation,  as  the impact of the potential common shares
(6,519,469  shares  at  September 30, 2006 and 2,273,094 shares at September 30,
2005) would be to decrease loss per share.  Therefore, diluted loss per share is
equivalent  to  basic  loss  per  share.

Stock-Based Compensation:

Beginning  July  1, 2006, the Company adopted the provisions of and accounts for
stock-based  compensation  in  accordance  with  the  Financial  Accounting


                                     F-8
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

Standards Board's ("FASB") Statement of Financial Accounting Standards No. 123 -
revised  2004  ("SFAS  123R")  "Share-Based Payment" which replaced Statement of
Financial  Accounting Standards No. 123("SFAS 123"), "Accounting for Stock-Based
Compensation" and supersedes APB Opinion No. 25 ("APB 25"), Accounting for Stock
Issued  to  Employees".  Under  the  fair  value  recognition provisions of this
statement,  stock-based compensation cost is measured at the grant date based on
the  fair  value  of  the  award and is recognized as expense on a straight-line
basis  over  the  requisite  service  period,  which  is the vesting period. The
Company  elected  the modified-prospective method, under which prior periods are
not  revised  for  comparative  purposes.  The valuation provisions of SFAS 123R
apply to new grants and to grants that were outstanding as of the effective date
and  are  subsequently  modified. There were no options granted during the three
months  ended  September 30, 2006 and 2005, and all options granted prior to the
adoption  of  SFAS  123R  and  outstanding  during  the  periods  presented were
fully-vested.

The  Company  has  two  stock  option  plans which permit the grant of shares to
attract,  retain  and  motivate  employees,  directors  and consultants of up to
625,000  shares of common stock.  Options are generally granted with an exercise
price equal to the Company's market price of its common stock on the date of the
grant  and  with  vesting  rates,  as determined by the Board of Directors.  All
options  outstanding at July 1, 2006 and September 30, 2006 are fully-vested and
exercisable.  A  summary  of  outstanding balances at July 1, 2006 and September
30,  2006  is  as  follows:

<TABLE>
<CAPTION>
                                      Weighted    Weighted
                                       average     average   Aggregate
                                      exercise   remaining   intrinsic
                             Options    price       life       value
                             -------  ---------  ----------  ----------
<S>                          <C>      <C>        <C>         <C>
     Outstanding at
       July 1, 2006 and
       September 30, 2006    398,127  $   22.00  4.61 years  $        0
</TABLE>

Recently  Issued  Accounting  Standards:

In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements". This
statement  defines  fair value, establishes a framework for measuring fair value
in  generally accepted accounting principles, and expands disclosures about fair
value measurements. This statement applies under other accounting pronouncements
that  require  or  permit fair value measurements. SFAS No. 157 is effective for
the  Company  for  its  fiscal  year  beginning  on July 1, 2008. The Company is
currently  assessing  the  impact  the adoption of SFAS No. 157 will have on its
consolidated  financial  statements.

In  September  2006,  the  SEC issued Staff Accounting Bulletin (SAB) No. 108 in
order  to  eliminate  the diversity of practice surrounding how public companies
quantify  financial  statement  misstatements.  In  SAB  108,  the  SEC  staff
established  an  approach  that  requires  quantification of financial statement
misstatements based on the effects of the misstatements on each of the Company's
financial  statements  and  the related financial statement disclosures. SAB No.
108  is  effective  for  the  Company  for  its  current  fiscal


                                     F-9
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

year.  The  adoption  of  SAB  No.  108  did not have an impact on the Company's
consolidated  financial  statements.

2.   NOTES RECEIVABLE  -  EQUITY  INVESTEE:

During  the  year  ended  June  30,  2006,  the  Company  loaned  $1,726,827  to
BioAgra(Note 3) in exchange for a secured, 7.5% promissory note with payments to
be  made  monthly starting October 31, 2006, through October 31, 2007. The funds
were  loaned to facilitate BioAgra's completion of its first production line and
to  support  operations.  The  promissory  note is collateralized by all BioAgra
assets.  Additionally,  the  promissory  note is to be paid in full prior to any
distributions  being  made to the members of the joint venture. At September 30,
2006,  the  note  was  reduced  by  $197,589, which represents the excess of the
BioAgra  losses  recognized  by  the  Company  over  the  adjusted  basis of the
Company's equity investment in BioAgra remaining at September 30, 2006 (Note 3).

During  the quarter ended September 30, 2006, the Company advanced an additional
$191,000  to  BioAgra  under  the  same  terms as the promissory note, described
above.  In  October  2006, the Company advanced an additional $67,450 to BioAgra
under  the  same  terms as the promissory note, described above. The Company has
classified  these  notes receivable as long-term assets on the balance sheet and
is  not  accruing  interest  on  these notes receivable as they are currently in
default  and  non-performing.  The  scheduled  October  2006  payment under the
promissory  note  was  not  made.

3.   INVESTMENTS  IN  AFFILIATES:

Investment in EPT:

The  carrying amount of the Company's investment in EPT is $198,747 at September
30,  2006,  and  is  adjusted  to recognize the Company's proportionate share of
EPT's  income  (loss)  each  period.

Unaudited  financial  information  of  EPT as of September 30, 2006, and for the
three-month  periods  ended  September  30,  2006  and  2005  are  as  follows:

<TABLE>
<CAPTION>
                                              September 30,
                                                  2006
                                             --------------
<S>                                          <C>
     Assets:
         Current assets(1)                   $      553,125
         Equipment                                   66,257
                                             --------------

       Total assets                          $      619,382
                                             ==============

     Liabilities and members' equity:
         Current liabilities(2)              $      355,888
         Members' equity                            263,494
                                             --------------
     Total liabilities and members' equity   $      619,382
                                             ==============
</TABLE>

     (1)  Current  assets  include  receivables  of  $226,905  due  from the 51%
          owner  of  EPT.
     (2)  Current  liabilities  include  a  payable  of  $30,544  due to the 51%
          owner  of  EPT.


                                      F-10
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

<TABLE>
<CAPTION>
                   Three Months     Three Months
                       Ended            Ended
                   September 30,    September 30,
                       2006             2005
                  ---------------  ---------------
<S>               <C>              <C>
     Revenues(1)  $      568,551   $      399,736
     Expenses(2)        (492,331)        (434,313)
                  ---------------  ---------------
     Net income
       (loss)     $       76,220   $      (34,577)
                  ===============  ===============
</TABLE>

     (1)  Revenues  include  $568,551  and  $272,327,  respectively  of sales to
          the  51%  owner  of  EPT  for  each  period  presented.
     (2)  Expenses  include  $38,278  and  $7,915,  respectively of charges paid
          to  the  51%  owner  of  EPT  for  each  period  presented.

Investment in BioAgra:

On  August  15,  2005,  the  Company  entered  into  a  joint  venture with Xact
Resources,  a  privately-held  company.  The  Company  purchased  a  50%  equity
interest  in  the  joint  venture, BioAgra, for $905,000 in cash (which includes
$405,000  previously  advanced to Xact Resources as of June 30, 2005) and a note
payable  of  $595,000, which was paid in full on September 15, 2005.  BioAgra is
to  manufacture  and  sell  a  beta  glucan  product,  YBG-2000  also  known  as
AgraStimTM,  to  be  used  as  a  replacement  for  hormone  growth steroids and
antibiotics in products such as poultry feed.  As of September 30, 2006, BioAgra
(a  development  stage  company) has completed construction of a production line
and  has  produced  and  shipped  product  in  limited  quantities.

The  terms of the joint venture provide for the Company to share in 50% of joint
venture  net income, if any, or net losses.  Net losses incurred by BioAgra have
exceeded  the  underlying  equity  attributed  to  BioAgra's other joint venture
investor.  As a result, the excess of the losses attributable to the other joint
venture  investor have been charged to the Company.  BioAgra incurred a net loss
of  $304,905  for  the  three months ended September 30, 2006.  As a result, the
carrying  value of the Company's investment in BioAgra at September 30, 2006 was
reduced  from  $107,316  to  $0.  The remaining portion of the losses ($197,589)
were  applied  to  reduce  the  value  of  the  notes  due  from  BioAgra.

Unaudited  financial information of BioAgra as of September 30, 2006 and for the
three  months  ended  September  30,  2006,  and the period from August 15, 2005
(inception)  through  September  30,  2005,  is  as  follows:

<TABLE>
<CAPTION>
                                                  September 30,2006
                                                 -------------------
<S>                                              <C>
     Assets:
         Current assets                          $          168,033
         Land, building and equipment, net                2,935,340
         Other assets, net                                   94,384
                                                 -------------------

       Total assets                              $        3,197,757
                                                 ===================

     Liabilities and members' equity:
         Current liabilities(1)                  $        2,404,111
         Obligation under capital lease(1)                  991,233
                                                 -------------------

       Total liabilities                                  3,395,344

         Members' deficiency                               (197,587)
                                                 -------------------

     Total liabilities and members' deficiency   $        3,197,757
                                                 ===================
</TABLE>

     (1)  Includes  $1,951,536  owed  to  the  Company.
     (2)  BioAgra  leases  land  and  a  building  under  a  ten-year  lease
          expiring  in  February 2015, which requires a monthly lease payment of
          $12,000.


                                      F-11
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

<TABLE>
<CAPTION>
                                       August 15, 2005
                Three Months Ended         through
                September 30, 2006   September 30, 2005
               --------------------  -------------------
<S>            <C>                   <C>
     Revenues  $            31,642                    -
     Expenses         (    336,547)         (   485,930)
               --------------------  -------------------
     Net loss  $      (    304,905)         (   485,930)
               ====================  ===================
</TABLE>

4.   ADVANCES  PAYABLE  -  RELATED  PARTY:

In  June  2006,  the  Company  received  an  advance  of  $140,000  from Arizcan
Properties,  Ltd.  (Arizcan).  Total advances received at September 30, 2006 are
$240,000. The advances are to be applied to an equity placement that the Company
and Arizcan have not yet finalized. The proceeds were used to fund the Company's
operations.

5.   COMMITMENTS  AND  CONTINGENCIES

LITIGATION:

Depository  Trust  Suit:

In  May  2004,  the Company filed suit against the Depository Trust and Clearing
Corporation  ("DTCC"),  the  Depository  Trust Company ("DTC"), and the National
Securities  Clearing  Corporation ("NSCC") in the Second Judicial District Court
of  the  County  of  Washoe,  State of Nevada.  The suit alleges multiple claims
under  the  Nevada  Revised  Statutes 90.570, 90.580, 90.660 and 598A.060 and on
other  legal  bases.  The  complaint alleges, among other things, that the DTCC,
DTC  and NSCC acted in concert to operate the "Stock Borrow Program," originally
created  to address short term delivery failures by sellers of securities in the
stock  market.  According  to the complaint, the DTCC, NSCC and DTC conspired to
maintain  significant  open  fail deliver positions of millions of shares of the
Company's  common  stock  for extended periods of time by using the Stock Borrow
Program  to  cover  these open and unsettled positions.  The Company was seeking
damages  in  the amount of $25,000,000 and treble damages.  Responsive pleadings
have  been  filed  by  the  defendants.  On  April 27, 2005, the court granted a
motion  to  dismiss the lawsuit. The Company has filed an appeal to overturn the
motion  to  dismiss  the  lawsuit.

Financing  Agreement  Suit:

In  connection  with  a  financing  obtained  in October 2000, the Company filed
various actions in the United States District Court for the District of Colorado
against,  among  others,  Harvest  Court,  LLC,  Southridge  Capital


                                      F-12
<PAGE>
                           VYTA CORP AND SUBSIDIARIES
            Notes to the Condensed Consolidated Financial Statements
                 Three Months Ended September 30, 2006 and 2005
                                   (Unaudited)

Investments,  LLC,  Daniel  Pickett, Patricia Singer and Thomson Kernaghan, Ltd.
for  violations  of  federal  and  state securities laws, conspiracy, aiding and
abetting  and  common  law  fraud  among  other  claims.  As a result of various
procedural  rulings,  in  January 2002, the United States District Court for the
District  of  Colorado  transferred the case to the United States District Court
for  the  Southern  District  of  New  York,  New  York City, New York.  In this
litigation,  Harvest  Court,  LLC  filed  counterclaims  against the Company and
certain  officers  and  former  board  members  of  the Company, and a number of
unrelated  third  parties.  The  counterclaims  allege  violations  of  federal
securities  laws and other laws.  Harvest Court, LLC is seeking various forms of
relief  including  compensatory and punitive damages.  Responsive pleadings have
been  filed  and  the  litigation  is  currently  in  the  discovery  stage.

In  May  2001,  Harvest Court, LLC filed suit against the Company in the Supreme
Court  of  the State of New York, County of New York.  The suit alleges that the
Company  breached  an  October 20, 2000 Stock Purchase Agreement, by not issuing
7,418,895  free  trading shares of the Company's common stock in connection with
the  reset provisions of the Purchase Agreement due on the second reset date and
approximately  4,500,225  shares  due  in  connection with the third reset date.
Harvest  Court,  LLC  is  seeking  the delivery of such shares or damages in the
alternative.  In August 2001, the Supreme Court of the State of New York, County
of  New York issued a preliminary injunction ordering the Company to reserve and
not  transfer  the  shares allegedly due to Harvest Court, LLC.  The Company has
filed  counterclaims seeking various forms of relief against Harvest Court, LLC.

The Company intends to vigorously prosecute this litigation and does not believe
the  outcome  of  this  litigation  will  have  a material adverse effect on the
financial  condition,  results  of  operations  or  liquidity  of  the  Company.
However, it is too early at this time to determine the ultimate outcome of these
matters.


                                      F-13
<PAGE>
ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS

     Certain  statements  contained in this Form 10-QSB contain "forward-looking
statements"  within  the meaning of the Private Securities Litigation Reform Act
of  1995  and involve risks and uncertainties that could cause actual results to
differ  materially  from  the  results,  financial  or  otherwise,  or  other
expectations  described in such forward-looking statements.  Any forward-looking
statement  or statements speak only as of the date on which such statements were
made,  and  the  Company  undertakes no obligation to update any forward-looking
statement  to  reflect  events  or  circumstances  after  the date on which such
statements  are  made  or  reflect  the  occurrence  of  unanticipated  events.
Therefore, forward-looking statements should not be relied upon as prediction of
actual  future  results.

     The independent registered public accounting firm's report on the Company's
consolidated financial statements as of June 30, 2006, and for each of the years
in  the  two-year  period  then  ended,  includes  a "going concern" explanatory
paragraph,  that  describes  substantial  doubt  about  the Company's ability to
continue  as  a  going  concern.  Management's  plans  in  regard to the factors
prompting  the  explanatory  paragraph are discussed below and also in Note 1 to
the  unaudited  quarterly  financial  statements.

RESULTS  OF  OPERATIONS

     The  Company  had  no  revenues during the three months ended September 30,
2006  and  2005.

     Total  general  and  administrative  expenses during the three months ended
September 30, 2006 were $275,414 compared to $224,429 for the three months ended
September  30,  2005.  The  increase  of $50,985, is primarily attributable to a
$84,891  increase  in consulting fees and a $20,630 increase in accounting fees,
offset  by  a  $33,160  decrease  in  commission  expense.

     The  Company  recognized  $3,931 in interest income during the three months
ended September 30, 2005.  During the three months ended September 30, 2005, the
Company  recognized  $28,585  in  other  income, which represented a gain on the
extinguishment  of  certain  liabilities.

     No  interest  expense  was recorded during the three months ended September
30,  2006, as no debt was outstanding during the period.  The Company recognized
interest  expense of $235,328 for the three months ended September 30, 2005.  Of
the  $235,328  in interest expense, $219 represented related party interest. The
remaining  $235,109  was  incurred in connection with the issuance of promissory
notes,  which  were discounted for the fair value of warrants included with debt
at the time of issuance.  The resulting discounts ($213,760) were amortized over
the term of the promissory notes.  The promissory notes were paid in full during
the  three  months ended September 30, 2005, and at that time the discounts were
fully  amortized.

     During  the three months ended September 30, 2006, the Company recognized a
net  loss of $542,972 compared to a net loss of $687,149 during the three months
ended  September  30,  2005.  The  decrease of $144,177, during the three months
ended  September 30, 2006, is primarily attributable to the decrease of $235,109
in  interest  expenses,  offset  by  the  increase  of  $50,985  in  general and
administrative  expenses.


                                        1
<PAGE>
LIQUIDITY  AND  FINANCIAL  CONDITION

     During the three months ended September 30, 2006, the Company used $129,514
in operating activities. Net cash provided by financing activities was $140,000,
which  is  a  prepayment  on  a series of preferred stock the terms of which are
being negotiated.  Net cash used in investing activities was $191,000, which was
advanced  to  BioAgra  to  be  used  to support its operations.  The Company had
$11,845  of cash and cash equivalents at September 30, 2006, which is being used
to  support  operations.  During  the three months ended September 30, 2005, the
Company  used  $230,782  in operating activities.  During the three months ended
September  30,  2005, net cash provided by financing activities was $724,337; of
which  $1,535,000 was from the exercise of warrants, $150,000 were proceeds from
the issuance of notes payable and common stock and $960,663 was used to pay note
payable.

     In  August  2005, the Company purchased a 50% equity interest in BioAgra (a
Georgia  limited  liability  company)  for  $905,000  cash  (which  includes the
$405,000  advanced to Xact Resources during the fiscal year ended June 30, 2005)
and  a  note  payable  of  $595,000  which  was  paid in full in September 2005.
BioAgra  plans  to manufacture and sell a beta glucan product, YBG-2000 marketed
as  AgriStim,  to  be  used  as  a  replacement  for hormone growth steroids and
antibiotics  in animal feed products.  BioAgra has completed the construction of
its  production  line  and  during  the  three  months ended September 30, 2006,
BioAgra  had  limited  sales  of  its  product.

     As  of September 30, 2006, if all existing outstanding warrants issued in a
January  2004  private placement were exercised, the Company will be required to
issue an additional 1,342,500 shares of common stock and would receive $192,125,
and  the Company, on a fully diluted basis (including the reservation of 832,029
shares  as  required  by the court in the Financing Agreement Litigation), would
have  29,995,271  shares  of  common  stock  issued  and  outstanding.

     However,  no  assurance  can  be  given  that any of these warrants will be
exercised.  If  the  warrants are exercised, the Company has decided that it may
use the additional funds received from the exercise of these warrants to support
the  operations  of  the  Company  and  its  investments.

     During  the 2007 fiscal year the Company intends to continue its efforts to
aid  BioAgra  with  the  continuing  development  of  its  sales, nationally and
internationally  in  other animal feed markets, such as the equine and the swine
markets.   In  addition,  the  Company  has  begun  negotiations with interested
parties,  to  license its NCOS(TM) technology.  At this time, no terms have been
finalized,  though  the  Company  believes  that by the end of the quarter ended
December  31,  2006,  a  license  will  have  been  finalized  and  granted.

     The  Company intends to raise additional funds to support operations of the
Company  during  the  2007  fiscal year.  Such funds are to be raised through an
offering  of  a  preferred stock, the terms of which are in the process of being
finalized.

     To  the  extent  the  Company's  operations  are not sufficient to fund the
Company's  capital  requirements  the  Company  may  enter into a revolving loan
agreement  with  financial  institutions or attempt to raise capital through the
sale  of  additional  capital  stock  or  through  the issuance of debt.  At the
present  time  the  Company  does  not  have a revolving loan agreement with any


                                        2
<PAGE>
financial  institution nor can the Company provide any assurance that it will be
able  to  enter  into any such agreement in the future or be able to raise funds
through  the  further  issuance  of  debt  or  equity  in  the  Company.

RECENTLY  ISSUED  ACCOUNTING  STANDARDS:

     In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements".
This  statement  defines  fair value, establishes a framework for measuring fair
value in generally accepted accounting principles, and expands disclosures about
fair  value  measurements.  This  statement  applies  under  other  accounting
pronouncements  that require or permit fair value measurements.  SFAS No. 157 is
effective  for  the  Company for its fiscal year beginning on July 1, 2008.  The
Company is currently assessing the impact the adoption of SFAS No. 157 will have
on  its  consolidated  financial  statements.

     In  September  2006,  the  SEC issued SAB No. 108 in order to eliminate the
diversity  of  practice  surrounding  how  public  companies  quantify financial
statement misstatements.  In SAB 108, the SEC staff established an approach that
requires  quantification  of  financial  statement  misstatements  based  on the
effects  of  the misstatements on each of the Company's financial statements and
the  related  financial statement disclosures.  SAB No. 108 is effective for the
Company  for  its current fiscal year.  The adoption of SAB No. 108 did not have
an  impact  on  the  Company's  consolidated  financial  statements.

ITEM  3.  CONTROLS  AND  PROCEDURES

As  of  the  end  of the period covered by this Quarterly Report on Form 10-QSB,
the  Company  carried  out  an  evaluation,  under  the supervision and with the
participation  of  the  Company's  President and Chief Financial Officer, of the
effectiveness  of  the design and operation of the Company's disclosure controls
and  procedures  (as such term is defined in Rules 13a-14(c) and 15d-14(c) under
the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Based upon
such  evaluation,  such  officers  have  concluded that the Company's disclosure
controls  and  procedures  are  effective as of the end of the period covered by
this  quarterly  report  on  Form 10-QSB in alerting them, on a timely basis, to
material  information  relating  to  the  Company required to be included in the
Company's  periodic  SEC  filings  and to ensure that information required to be
disclosed  in the Company's periodic SEC filings is accumulated and communicated
to  the  Company's  management,  including  its  President  and  Chief Financial
Officer,  to  allow  timely  decisions  regarding  required  disclosure.

There  was  no  change  to  the  Company's  internal  controls  over  financial
reporting during the fiscal quarter ended September 30, 2006 that has materially
affected,  or  is reasonably likely to materially affect, the Company's internal
controls  over  financial  reporting.


                                        3
<PAGE>
                           PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS - NO CHANGE.


                           PART II - OTHER INFORMATION

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS - NONE.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES - NONE.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS - NONE.

ITEM 5.  OTHER INFORMATION - NONE.


                                        4
<PAGE>
ITEM  6.     EXHIBITS

     EXHIBITS.  The  following  is  a  complete  list  of exhibits filed as part
     of  this  Form  10-QSB.  Exhibit  numbers  correspond to the numbers in the
     Exhibit  Table  of  Item  601  of  Regulation  S-B.

          Exhibit 31.1  Certification  of  Chief  Executive  Officer pursuant to
                        Section  302  of  the  Sarbanes-Oxley  Act

          Exhibit 31.2  Certification  of  Chief  Financial  Officer pursuant to
                        Section  302  of  the  Sarbanes-Oxley  Act

          Exhibit 32.1  Certification  of  Principal  Executive  Officer
                        pursuant  to  Section  906  of  the  Sarbanes-Oxley  Act

          Exhibit 32.2  Certification  of  Principal  Financial  Officer
                        pursuant  to  Section  906  of  the  Sarbanes-Oxley  Act


                                        5
<PAGE>
                                   SIGNATURES

     In accordance with the requirements of the Securities Exchange Act of 1934,
the  registrant  has  duly  caused this report to be signed on its behalf by the
undersigned,  thereunto  duly  authorized.

                                                VYTA CORP
                                               (REGISTRANT)

Date:  November 20, 2006                   /s/  Paul  H.  Metzinger
                                           -------------------------------------
                                           Paul  H.  Metzinger,
                                           President  &  CEO
                                           (Principle  Executive  Officer)


Date:  November 20, 2006                   /s/ Kristi J. Kampmann
                                           -------------------------------------
                                           Kristi  J.  Kampmann,
                                           Chief  Financial  Officer
                                           (Principle  Financial  Officer)


                                       6